Transenterix Inc’s Sentiment

“Big money sentiment for Transenterix Inc (NYSEMKT:TRXC) in 2018 Q4 decreased to 1.14, SEC filings reveal. That’s down -1.23, from 2018Q3’s 2.37. 58 funds increased and opened new stock positions, while 51 decreased and sold stakes in Transenterix Inc so the sentiment is negative. These funds own 71.13 million shares, that’s up from 70.16 million shares in 2018Q3. Funds holding Transenterix Inc in top 10 decreased from 3 to 2 for a decrease of 1. In total 17 funds closed positions, 34 reduced and 35 increased. Also 23 funds bought new Transenterix Inc stakes.

Significant Transenterix Inc Investors

Sv Health Investors Llc owns 6.63 million shares in Transenterix Inc as of 2018 Q4. Transenterix Inc’s shareholder Aisling Capital Llc owns 2.39 million shares as of 2018 Q4. Moreover, Masters Capital Management Llc reported 1.75 million shares in Transenterix Inc equivalent to 0.22% of its stocks portfolio. The California-based fund Eam Investors Llc have invested about 0.13% of the investment professional’s stock portfolio in Transenterix Inc. The Delaware-based fund Brandywine Managers Llc holds 92,283 shares or 0.1% of their stocks portfolio.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems.The firm is valued at $514.39 million. The firm offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.Currently it has negative earnings. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

Ticker’s shares touched $2.37 during the last trading session after 0.42% change.Currently TransEnterix, Inc. is uptrending after 38.50% change in last April 1, 2018. TRXC has also 211,659 shares volume. TRXC outperformed by 34.13% the S&P 500.

On May, 14 WallStreet awaited TransEnterix, Inc. (NYSEAMERICAN:TRXC)’s earnings report, according to Zacks. Last year’s EPS was $-0.06, while now analysts expect change of 16.67 % down from current $-0.07 EPS. After $-0.07 EPS report last quarter, Wall Street now sees 0.00 % EPS growth of TransEnterix, Inc..

Alps Incorporated reported 142,951 shs stake. Hm Payson And owns 0.01% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 1,740 shs. 7,075 were accumulated by Pittenger And Anderson. Northern Trust owns 1.97M shs or 0% of their US capital. Tiaa Cref Inv Management Limited Liability Corporation owns 315,688 shs for 0% of their capital. Mcf Llc holds 1,500 shs. Comerica Comml Bank accumulated 23,198 shs. Lifeplan Group owns 1,000 shs. Invesco Limited holds 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC) or 34,309 shs. Bnp Paribas Arbitrage reported 0% stake. First Manhattan Communications invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% of its capital in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Rhumbline Advisers has 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 210,898 shs. 7.73M are owned by Jpmorgan Chase. Cetera Advsrs Limited Liability holds 0% or 14,800 shs.

For more TransEnterix, Inc. (NYSEAMERICAN:TRXC) news posted briefly go to: Businesswire.com, Prnewswire.com, Businesswire.com, Businesswire.com or Businesswire.com. The titles are as follows: “TransEnterix Named to Deloitte’s Technology Fast 500 – Business Wire” posted on November 15, 2018, “SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors – PRNewswire” on March 19, 2019, “TransEnterix Receives FDA 510(k) Clearance for Senhance Ultrasonic System – Business Wire” with a publish date: January 15, 2019, “TransEnterix, Inc. to Join the Russell 2000® Index – Business Wire” and the last “TransEnterix Announces Senhance US Sale Agreement With Florida Hospital – Business Wire” with publication date: November 13, 2017.